The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.
We all know that asthma impacts breathing. What may be less known is that the disease, which restricts our airways due to inflammatory responses, can be caused throughout our lifetime by a variety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback